bf/NASDAQ:ARVN_icon.jpeg

COM:ARVINAS

Arvinas, Inc.

  • Stock

USD

Last Close

25.11

22/11 21:00

Market Cap

1.80B

Beta: -

Volume Today

1.04M

Avg: -

  • name

    Arvinas, Inc.
  • homepage url

    www.arvinas.com
  • country

    USUnited States
  • linkedin url

    arvinas
  • crunchbase url

    arvinas
  • employee count

    445
  • sector

    Healthcare
  • industry

    Biotechnology
  • revenue

    78.50M

Description

Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of...Show More

peer of

investor of

competitor of